|4Feb 24, 4:46 PM ET

Bures Thomas 4

4 · PIERIS PHARMACEUTICALS, INC. · Filed Feb 24, 2022

Insider Transaction Report

Form 4
Period: 2022-02-22
Bures Thomas
Vice President, Finance
Transactions
  • Award

    Stock Options (Right to buy)

    2022-02-22+215,819215,819 total
    Exercise: $3.03Exp: 2032-02-22Common Stock (215,819 underlying)
Footnotes (1)
  • [F1]The option vests as to 25% of the option shares on February 22, 2023 and as to an additional 6.25% of the option shares at the end of each successive three-month period thereafter.

Documents

2 files
  • 4
    primarydocument.xmlPrimary

    PRIMARY DOCUMENT

  • EX-24

    TBURESPOA